Impact of the Digital Multi-domain Cognitive Intervention in High-risk Populations for Dementia

Recruiting N/A Interventional Study
Cognitive Dysfunction
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
55 and older
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
128 (estimated)
Sponsor
Fujian Provincial Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Dementia is a chronic, progressive neurodegenerative disease characterized by acquired cognitive impairment as its core manifestation. The most common type of dementia is Alzheimer's Disease (AD), also known as "Senile Dementia," accounting for 60-80% of all dementia cases. Currently, there are approximately 10 million AD patients in China, with the number showing an increasing trend year by year,…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * MCI (refer to Peterson's diagnostic criteria) or SCD (refer to the diagnostic framework proposed by Jak bondi and Jessen et al.); * Able to communicate normally in Mandarin; * Certain level of comprehension and judgment abilities, aware of the purpose of the survey and consent…
Contacts

lian fayang, MD

0591-87557768

fjslkyk@163.com

CONTACT

Yuanjiao Yan, PhD

18120826271

yuanjiao1994@126.com

CONTACT